Investment Research & Advisory Group, Inc. Novartis Ag Transaction History

Investment Research & Advisory Group, Inc.

$236 Million
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 19, 2022	SELL	$79.7 - $88.13 $46,863 - $51,820	-588 Reduced 24.37%	1,825 $160,000
Q2 2021 Jul 29, 2021	SELL	$85.24 - $94.15 $1.24 Million - $1.37 Million	-14,575 Reduced 85.8%	2,413 $220,000
Q1 2021 Apr 29, 2021	SELL	$83.5 - $98.47 $7,598 - $8,960	-91 Reduced 0.53%	16,988 $1.45 Million
Q4 2020 Feb 16, 2021	BUY	$78.07 - $94.43 $39,737 - $48,064	509 Added 3.07%	17,079 $1.61 Million
Q3 2020 Oct 29, 2020	SELL	$82.14 - $91.0 $54,951 - $60,879	-669 Reduced 3.88%	16,570 $1.44 Million
Q2 2020 Aug 04, 2020	BUY	$80.93 - $91.1 $491,164 - $552,885	6,069 Added 54.33%	17,239 $1.5 Million
Q1 2020 Apr 30, 2020	BUY	$70.67 - $99.01 $44,239 - $61,980	626 Added 5.94%	11,170 $921,000
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $889,386 - $1.01 Million	10,544 New	10,544 $998,000

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Investment Research & Advisory Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Investment Research & Advisory Group, Inc. with notifications on news.

Account